Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Samin K Sharma, MD
Icahn School of Medicine at Mount Sinai
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
34 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Arkansas Heart Hospital
Little Rock, Arkansas, United States
- Glendale Adventist Medical Center
Glendale, California, United States
- Hartford Hospital
Hartford, Connecticut, United States
- Medstar Washington Hospital
Washington D.C., District of Columbia, United States
- Clearwater Cardiovascular & Interventional Consultants
Clearwater, Florida, United States
- Mount Sinai Medical Center Heart Institute
Miami Beach, Florida, United States
- Cardiovascular Institute of Nw Florida
Panama City, Florida, United States
- Georgia Regents Research Institute
Augusta, Georgia, United States
- University of Chicago Medical Center
Chicago, Illinois, United States
- Prairie Education & Research Cooperative
Springfield, Illinois, United States
- Indiana University
Indianapolis, Indiana, United States
- John Hopkins
Baltimore, Maryland, United States
- Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
- Tufts Medical Center
Boston, Massachusetts, United States
- Baystate Medical Center
Springfield, Massachusetts, United States
- Mclaren Bay Regional
Bay City, Michigan, United States
- Beaumont Hospital
Royal Oak, Michigan, United States
- Boone Hospital
Columbia, Missouri, United States
- Saint Luke'S
Kansas City, Missouri, United States
- Barnes Jewish Hospital
St Louis, Missouri, United States
- Hackensack University Medical Center
Hackensack, New Jersey, United States
- Jersey Shore Medical Center
Neptune City, New Jersey, United States
- Mount Sinai New York
New York, New York, United States
- Duke University Medical Center
Durham, North Carolina, United States
- East Carolina University
Greenville, North Carolina, United States
- North Carolina Heart & Vascular Specialists
Raleigh, North Carolina, United States
- Ohiohealth Research Institute
Columbus, Ohio, United States
- St. John Health System
Tulsa, Oklahoma, United States
- University Pittsburg Mc - Hamot
Erie, Pennsylvania, United States
- Allegheny General Hospital
Pittsburgh, Pennsylvania, United States
- University of Tennessee
Memphis, Tennessee, United States
- Houston Methodist Research Institute
Houston, Texas, United States
- Mission Research Institute
New Braunfels, Texas, United States
- Providence Health Center
Waco, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 26 Sept 2013
- Primary completion
- 7 Nov 2016
- Completion
- 1 Jun 2017
- Last update posted
- 18 Jul 2023
- Registered enrollment
- 350
- Registry id
- NCT01930214
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.